Analytics firm predicts global psoriasis market to grow twofold by 2030
UK-based analytics firm Globaldata estimates that the market for psoriasis treatments will grow from USD 14.2bn to USD 27.5bn before 2030 – this growth will be based on eight upcoming drug candidates.
by ULRICH QUISTGAARD, translated by daniel pedersen
The international market for drugs against the skin disease psoriasis will annually grow by 6.8 percent on average by 2030, when the market will total USD 27.5bn, UK-based analytics firm Globaldata reports in a press release.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
